Source: BioSpace

Diasource: <b>BioVendor</b> Acquires 100% Of The Shares Of <b>DIAsource ImmunoAssays SA</b>

LOUVAIN-LA-NEUVE, schema.org/Place">

Read full article »
Diasource's Competitors | Diasource's News | Diasource's Financials
Stay up-to-date with the latest news on Diasource
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Jozef Vangenechten's photo - CEO of Diasource

CEO

Jozef Vangenechten

CEO Approval Rating

69/100

Read more
Stay up-to-date with the latest news on Diasource